Riskpilot← Back to searchSign inGet full accessAPOPAK A.M.B.A.
ABAActiveCVR 26528631Fruebjergvej 3Rental and leasing of other machinery, equipment and tangible goods n.e.c. · NACE 7739Est. 2002— employees
Revenue 2025
DKK 4,8M
-31% vs 2024
EBITDA margin
96.5%
-33% vs 2024
Equity ratio
17.1%
Financial strength
Net profit 2025
DKK 815K
-83% vs 2024
| Revenue | DKK 4,8M | -31% |
| EBITDA | DKK 4,7M | -33% |
| Net profit | DKK 815K | -83% |
| Total assets | DKK 32,3M | +42% |
| Equity | DKK 5,5M | +3% |
| Employees | — | — |
Legal name
APOPAK A.M.B.A.
CVR number
26528631
Legal form
Andelsselskab (-forening) med begrænset ansvar
NACE code
7739 · Rental and leasing of other machinery, equipment and tangible goods n.e.c.
Founded
25. marts 2002
Share capital
—
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med den administrerende direktør, af næstformanden i forening med den administrerende direktør, eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at investere i fast ejendom, herunder indgå lejemål, maskiner og andre aktiver, der kan benyttes til eller i forbindelse med køb og pakning af medicin, herunder dosisdispenseret medicin, at udleje ovenfor nævnte aktiver til en eller flere af selskabets andelshavere (leasingtagere) til brug for leasingtagernes drift af virksomhed indenfor køb af medicin til dosispakning, dosispakning af medicin og salg af den dosispakkede medicin, samt virksomhed, som efter bestyrelsens skøn er beslægtet med ovenfor nævnte. Herudover er selskabets formål at investere midler (helt eller delvist) i lignende eller andre aktiver, der - efter bestyrelsens rimelige skøn - kan betegnes som mindre risikobetonede.
Address
Fruebjergvej 3
Phone
+4570201413
Email
apotekeren@apotekerenamba.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.606 | 1.261 | 2.570 | 2.327 | 2.267 | 2.056 | 1.776 | 527 | 582 | 864 | 1.482 | 867 | 7.056 | 4.848 |
| Staff expenses | -87 | -87 | -100 | -100 | -100 | -100 | -100 | -100 | -100 | -100 | -100 | -100 | -100 | -169 |
| EBITDA | 1.519 | 1.173 | 2.470 | 2.227 | 2.167 | 1.956 | 1.676 | 427 | 482 | 764 | 1.382 | 767 | 6.956 | 4.679 |
| Depreciation & amort. | -1.366 | -1.079 | -2.184 | -2.032 | -2.014 | -1.911 | -1.643 | -391 | -409 | -700 | -811 | -747 | -881 | -2.915 |
| EBIT | 153 | 94 | 285 | 195 | 153 | 45 | 33 | 37 | 73 | 64 | 571 | 20 | 6.075 | 1.764 |
| Net financials | -60 | -128 | -217 | -156 | -134 | -33 | -27 | -29 | -37 | -39 | -31 | 25 | 36 | -689 |
| Profit before tax | 93 | -34 | 69 | 39 | 18 | 12 | 6 | 8 | 36 | 25 | 541 | 45 | 6.112 | 1.074 |
| Tax | 31 | -42 | -51 | 38 | 4 | 1 | 1 | 3 | 8 | 5 | 119 | 10 | 1.345 | 260 |
| Net profit | 62 | 8 | 120 | 0 | 14 | 11 | 5 | 5 | 28 | 19 | 422 | 35 | 4.767 | 815 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12.546 | 14.744 | 20.780 | 19.124 | 15.674 | 11.978 | 13.573 | 12.229 | 11.849 | 10.411 | 12.174 | 15.404 | 22.763 | 32.342 |
| Equity | 622 | 632 | 223 | 215 | 215 | 214 | 214 | 209 | 223 | 226 | 638 | 638 | 5.364 | 5.516 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.540 | 13.998 |
| Short-term debt | 11.924 | 14.112 | 20.557 | 18.909 | 15.459 | 11.764 | 13.359 | 12.020 | 11.626 | 10.186 | 11.536 | 14.766 | 9.858 | 12.692 |
| Total debt | 11.924 | 14.112 | 20.557 | 18.909 | 15.459 | 11.764 | 13.359 | 12.020 | 11.626 | 10.186 | 11.536 | 14.766 | 17.398 | 26.691 |
EBITDA margin
96.5%
This company
15.8%
Market median
+511% vs market
20122025
Equity ratio
17.1%
This company
38.2%
Market median
-55% vs market
20122025
Return on equity
14.8%
This company
18.4%
Market median
+20% vs market
20122025
Net profit margin
16.8%
This company
8.1%
Market median
+107% vs market
20122025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20122025
Debt / equity
4.86×
This company
0.62×
Market median
-684% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AM | Audit | 2002 | — | — |
PL Audit | Audit | 2009 | — | — |
DB Chief Executive Officer | Chief Executive Officer | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2002 | — | — | |
| Deputy Chairman | 2025 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2009 | — | — | |
| Deputy Chairman | 2014 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2009 | — | — | |
| Deputy Chairman | 2020 | — | — | |
| Deputy Chairman | 2017 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Chairman | 2023 | — | — | |
| Board of Directors | 2002 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of APOPAK A.M.B.A. also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alex Michael Ankjær-Jensen | Audit | 0 companies |
| Pia Lund Lillebæk | Audit | 0 companies |
| Dorte Brix Nagell | Chief Executive Officer | 0 companies |
| Lene Bjerring Damgaard | Board of Directors | 0 companies |
| Steffen Bo Asbjørn de Teilman Hald | Board of Directors | 0 companies |
| Ebbe Werenberg | Board of Directors | 0 companies |
| Jakob Møller | Deputy Chairman | 0 companies |
| Peer Nørkjær | Board of Directors | 0 companies |
| Thea Kæstel | Board of Directors | 0 companies |
| Sten Grønved Nielsen | Board of Directors | 0 companies |
| Camilla Bangert | Deputy Chairman | 0 companies |
| Ute Pørksen | Board of Directors | 0 companies |
| Christina Weidemann Pedersen | Board of Directors | 0 companies |
| Claude Cohr Lützen | Board of Directors | 0 companies |
| Peder Gunnersen Harboe | Board of Directors | 0 companies |
| Bente Wittrup Præstbrogaard | Board of Directors | 0 companies |
| Niels-Philip Bachmann Søgaard | Board of Directors | 0 companies |
| Niels Kristensen | Deputy Chairman | 0 companies |
| Jette Kristensen | Deputy Chairman | 0 companies |
| Inga Vilstrup | Board of Directors | 0 companies |
| Michael Bobak | Board of Directors | 0 companies |
| Per Wijngaard | Deputy Chairman | 0 companies |
| Steen Mejlgaard | Board of Directors | 0 companies |
| Trine Frost Hansen | Chairman | 0 companies |
| Kristian Østergaard Nielsen | Board of Directors | 0 companies |
| Peter Oksbjerg Krüger Bak | Board of Directors | 0 companies |